Influence of concurrent capecitabine based chemoradiotherapy with bevacizumab on the survival rate, late toxicity and health-related quality of life in locally advanced rectal cancer: a prospective phase II CRAB trial
Authors
Vaneja Velenik
Division of Radiotherapy, Institute of Oncology, Ljubljana, Slovenia
Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
Vesna Zadnik
Division of Epidemiology, Institute of Oncology, Ljubljana, Slovenia
Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
Mirko Omejc
Division of Surgery, University Medical Center Ljubljana, Ljubljana, Slovenia
Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
Jan Grosek
Division of Surgery, University Medical Center Ljubljana, Ljubljana, Slovenia
Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
Mojca Tuta
Division of Radiology, Institute of Oncology, Ljubljana, Slovenia
Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
Language: English
Page range: 461 - 469
Submitted on: Mar 1, 2020
Accepted on: Jun 13, 2020
Published on: Aug 1, 2020
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2020 Vaneja Velenik, Vesna Zadnik, Mirko Omejc, Jan Grosek, Mojca Tuta, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.